Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects
NCT05943379· Phase 2· RemeGen Co., Ltd.· Source
Contact: Zhisong He, Doctor
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error